These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 4298568

  • 21. [Role of prodigiozan in the overall therapy of dysentery in children].
    Sosnova MA, Zelenaia SN.
    Zdravookhr Kirg; 1976; (6):19-21. PubMed ID: 13573
    [No Abstract] [Full Text] [Related]

  • 22. [Effect of prodigiozan and pyrimidine derivatives on the effectiveness of the antibiotic therapy of experimental infections].
    Bakirov AB.
    Antibiotiki; 1979 Sep; 24(9):673-8. PubMed ID: 384893
    [Abstract] [Full Text] [Related]

  • 23. [Use of prodigiozan in the complex therapy of acute pneumonia].
    Gurvich SM, Skurkovich GV, Bokshteĭn ME, Vaĭsberg GE, Ermol'eva ZV.
    Klin Med (Mosk); 1970 Dec; 48(12):78-82. PubMed ID: 4932317
    [No Abstract] [Full Text] [Related]

  • 24. [Differential use of preformed physical factors in prodigiozan treatment of chronic salpingo-oophoritis].
    Strugatskiĭ VM, Rastorgueva VM, Tsoĭ S, Kudrina EA.
    Vopr Kurortol Fizioter Lech Fiz Kult; 1987 Dec; (2):66-8. PubMed ID: 3604127
    [No Abstract] [Full Text] [Related]

  • 25. [Use of prodigiozan and methacyl aerosols for the stimulation of the activity of lung macrophages in experiment].
    Dzhemukhadze NK, Eĭdel'shteĭn SI, Braude AI.
    Antibiotiki; 1969 Nov; 14(11):1030-4. PubMed ID: 4907799
    [No Abstract] [Full Text] [Related]

  • 26. [Use of prodigiozan for increasing the effectiveness of the antibiotic therapy of dysentery in children].
    Vereshchagin IA, Zhuravleva OD.
    Antibiotiki; 1984 Oct; 29(10):791-4. PubMed ID: 6439109
    [No Abstract] [Full Text] [Related]

  • 27. [Formation of marinamycin-like substance 10484 by Actinomyces candidus culture].
    Klitsunova NV, Ivanitskaia LP, Kudinova MK, Prozorovskaia NA, Kudrina ES I'auze GF.
    Antibiotiki; 1966 Nov; 11(11):967-73. PubMed ID: 5996400
    [No Abstract] [Full Text] [Related]

  • 28. [Acute toxicity, cytotoxic and local irritating effect of antibiotics of different chemical groups].
    Zak AF, Klimova NE, Ermolova OB.
    Antibiotiki; 1971 May; 16(5):446-50. PubMed ID: 4943415
    [No Abstract] [Full Text] [Related]

  • 29. [Use of prodigiozan in the combined therapy of infectious diseases (a review of the literature)].
    Frolov VM, Rychnev VE.
    Vrach Delo; 1986 Feb; (2):111-4. PubMed ID: 3518241
    [No Abstract] [Full Text] [Related]

  • 30. [Radio-protective properties of prodigiozan in experiment].
    Chertkov KS, Vaĭsberg GE, Khramchenkova SP, Rogozkin VD, Ermol'eva ZV.
    Antibiotiki; 1969 Nov; 14(11):1026-30. PubMed ID: 4907798
    [No Abstract] [Full Text] [Related]

  • 31. [Use of prodigiozan in serosols after cryotonsillotomy].
    Timofeev VT, Mukhitdinov ShM.
    Vestn Otorinolaringol; 1975 Nov; (1):59-61. PubMed ID: 1090061
    [No Abstract] [Full Text] [Related]

  • 32. [Modulation of phagocytic activity with prodigiozan and obsidan].
    Medvedev IuA, Alekhin EK, Iarmukhamedova AG.
    Antibiotiki; 1984 Nov; 29(11):848-51. PubMed ID: 6524886
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Effect of prodigiozan and cyclophosphane on the inflow of tumor cells into the blood channel].
    Solomonov AL, Pasternak NA, Givental' NI.
    Antibiotiki; 1967 Aug; 12(8):676-80. PubMed ID: 4871877
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Possibility of elimination of depression of the defense mechanisms of the body caused by antineoplastic antibiotics].
    Mazaeva VG.
    Antibiotiki; 1970 May; 15(5):447-9. PubMed ID: 4193822
    [No Abstract] [Full Text] [Related]

  • 37. [Prodigiozan effect of the distribution of antibiotics in blood and organs of rats].
    Kalinina NA, Geĭtman IIa, Balyn IR, Ermol'eva ZV.
    Antibiotiki; 1972 Jun; 17(6):532-5. PubMed ID: 4625691
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Combined use of prodigiozan and 8-mercaptoadenine for the stimulation of the antiviral resistance of cells].
    Braude AI, Vaĭsberg GE, Faĭnshteĭn SL, Shevniuk LA.
    Antibiotiki; 1970 Aug; 15(8):735-9. PubMed ID: 4321848
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.